Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Canada Lithium Updates on Lithium Carbonate Project

Jordan to Mine Uranium by 2013

Mongolian Government Looks to Gain a Larger Slice of Oyu Tolgoi Copper Mine

Platinex and Creso Exploration Report Sampling Results from Gold Corona-Pet Vein Pit Zones

Aquila Resources Reports New Drilling Results from Back Forty Project

Dynasty Gold Announces Phase I Drilling at Golden Repeat Property

Entrée Gold Receives Additional Assay Results from Ann Mason Deposit

Lundin Petroleum Completes Aldous Major North Exploration Well

Medallion Resources to Focus on Monazite

NMDC to Acquire Half of Australia's Legacy Iron Ore

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.